B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

GLUTATHIONE

MOLECULAR TARGET

Glutathione peroxidase 1 (human)

UniProt: P0720321 compounds

GLUTATHIONE (Glutathione peroxidase 1 (human)) is targeted by 21 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting GLUTATHIONE

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1amlexanox1.102
2vinpocetine0.691
3cefatrizine0.691
4Cefazolin0.691
5Cefdinir0.691
6Cefixime0.691
7Cefmenoxime0.691
8Cefotetan0.691
9Cefoxitin0.691
10Cefpodoxime0.691
11Cefprozil0.691
12ceftazidime0.691
13Ceftibuten0.691
14Cephaloglycin0.691
15Dipyrone0.691
16Dithiazanine 3-Ethyl-2-(5-(3-ethyl-2-benzothiazolinylidene)-1,3- pentadienyl)benzothiazolium.0.691
17Doxazosin0.691
18Irinotecan0.691
19silver sulfadiazine0.691
20stx640.691
21Thioctic Acid0.691

About GLUTATHIONE as a Drug Target

GLUTATHIONE (Glutathione peroxidase 1 (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 21 compounds with documented GLUTATHIONE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

GLUTATHIONE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.